Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.97% | -38.65% | -38.70% | 120.62% | -10.17% |
| Total Receivables | -38.46% | -36.60% | 10.35% | 9.07% | 20.33% |
| Inventory | 47.13% | -23.36% | 0.30% | -1.00% | -6.26% |
| Prepaid Expenses | -6.93% | 8.42% | 6.40% | -37.91% | 15.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.44% | -33.86% | -11.08% | 31.93% | 7.04% |
|
|
|||||
| Total Current Assets | -7.44% | -33.86% | -11.08% | 31.93% | 7.04% |
| Net Property, Plant & Equipment | 152.66% | -12.69% | -20.39% | -62.03% | 81.76% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -1.23% | -2.06% | -2.89% | -19.26% | 55.17% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -41.65% | 35.46% | -22.25% | 4.92% | -17.92% |
| Total Assets | -11.18% | -25.17% | -11.62% | 21.27% | 7.85% |
|
|
|||||
| Total Accounts Payable | 29.98% | -71.50% | 100.63% | 8.72% | -5.05% |
| Total Accrued Expenses | 0.01% | -5.14% | -18.16% | 0.46% | 50.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.47% | -7.50% | -97.67% | 8,142.94% | -52.00% |
| Total Finance Division Other Current Liabilities | -42.47% | -69.99% | 363.89% | 832.42% | -18.32% |
| Total Other Current Liabilities | -42.47% | -69.99% | 363.89% | 832.42% | -18.32% |
| Total Current Liabilities | -4.26% | -36.16% | -13.99% | 62.25% | 38.43% |
|
|
|||||
| Total Current Liabilities | -4.26% | -36.16% | -13.99% | 62.25% | 38.43% |
| Long-Term Debt | 0.20% | 0.65% | -3.21% | -36.69% | 0.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.07% | -10.28% | -11.00% | -12.16% | 271.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -36.58% | -78.23% | 257.56% |
| Total Liabilities | -2.10% | -21.87% | -10.22% | 2.72% | 14.73% |
|
|
|||||
| Common Stock & APIC | 0.47% | 0.49% | 0.76% | 0.63% | 1.45% |
| Retained Earnings | -3.38% | -0.72% | -0.88% | 6.51% | -5.31% |
| Treasury Stock & Other | 0.00% | -1.10% | 0.00% | -9.68% | 6.42% |
| Total Common Equity | -50.03% | -4.60% | -2.77% | 57.69% | -44.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -50.03% | -4.60% | -2.77% | 57.69% | -44.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -50.03% | -4.60% | -2.77% | 57.69% | -44.78% |
|
|
|||||
